Bisschop A, Bakker O, Meerman J H, van Wijk R, van der Heijden C A, Stavenuiter J F
Cancer Invest. 1984;2(4):267-77. doi: 10.3109/07357908409018441.
IP injection in rats of 2-acetylaminofluorene (AAF) or N-hydroxy-2-acetylaminofluorene (N-OH-AAF) resulted in a transient increase of hepatic ornithine decarboxylase (ODC) and tyrosine aminotransferase (TAT) activity. Maximal activity of ODC was observed 4 hr and of TAT 3 hr after administration of either AAF or N-OH-AAF. A lag-time of 2 hr preceded the increase of ODC and TAT activity. N-OH-AAF dependent ODC induction displayed an almost linear dose-response in the dose range up to 94.1 mumol/kg bw (body weight) when the ODC activity was measured at its maximum 4 hr after administration. Elevation of the dose N-OH-AAF to 126 mol/kg bw resulted in a lower ODC induction. Administration of doses AAF to 31.4 mumol did not change ODC activity. At doses up to 126 mumol/kg bw ODC induction increased linear. TAT induction increased linear in the dose range 15.7-94.1 mumol N-OH-AAF and 31.4-94.1 mumol AAF/kg. Lowering the dose of AAF did not result in a lower ODC or TAT activity. Judged by the effects of actinomycin D or cycloheximide administered 1 hr prior to AAF or N-OH-AAF, the in vivo induction of rat liver ODC activity by AAF and N-OH-AAF appeared to be under transcriptional control, whereas augmentation of TAT activity under influence of AAF or N-OH-AAF appeared the result of (post) translational events. Induction of ODC by AAF or N-OH-AAF was not significantly changed by indomethacin, was slightly increased by pentachlorophenol (PCP) and was synergistically enhanced by retinylacetate (RA). The increase of TAT activity was stimulated by PCP and RA. The effect of PCP indicates that N-sulfonoxy-2-acetylaminofluorene is most probably not involved in the induction of ODC. AAF appeared more effective hepatic ODC inducer in females than males and moreover more effective than N-OH-AAF in females. N-OH-AAF had stronger ODC inducing capacity in males than females. Similar observations were made with respect to TAT activity. When induction of ODC is indicative for a tumor promoting property then the data presented here suggest that tumor promotion of the complete carcinogens AAF and N-OH-AAF is not mediated by N-O-sulfation; this might be due to other metabolic conversions.
给大鼠腹腔注射2-乙酰氨基芴(AAF)或N-羟基-2-乙酰氨基芴(N-OH-AAF)会导致肝脏鸟氨酸脱羧酶(ODC)和酪氨酸转氨酶(TAT)活性短暂升高。注射AAF或N-OH-AAF后4小时观察到ODC的最大活性,3小时观察到TAT的最大活性。ODC和TAT活性升高之前有2小时的延迟期。当在给药后4小时测量ODC活性的最大值时,在高达94.1 μmol/kg体重(bw)的剂量范围内,N-OH-AAF依赖性ODC诱导呈现几乎线性的剂量反应。将N-OH-AAF的剂量提高到126 μmol/kg bw会导致较低的ODC诱导。给予高达31.4 μmol的AAF剂量不会改变ODC活性。在高达126 μmol/kg bw的剂量下,ODC诱导呈线性增加。在15.7 - 94.1 μmol N-OH-AAF和31.4 - 94.1 μmol AAF/kg的剂量范围内,TAT诱导呈线性增加。降低AAF的剂量不会导致较低的ODC或TAT活性。根据在AAF或N-OH-AAF给药前1小时给予放线菌素D或环己酰亚胺的效果判断,AAF和N-OH-AAF对大鼠肝脏ODC活性的体内诱导似乎受转录控制,而在AAF或N-OH-AAF影响下TAT活性的增强似乎是(翻译后)翻译事件的结果。吲哚美辛对AAF或N-OH-AAF诱导ODC的作用无显著影响,五氯苯酚(PCP)使其略有增加,视黄酸(RA)则协同增强其作用。PCP刺激TAT活性增加。PCP的作用表明N-磺酰氧基-2-乙酰氨基芴很可能不参与ODC的诱导。AAF在雌性中似乎比雄性更有效地诱导肝脏ODC,而且在雌性中比N-OH-AAF更有效。N-OH-AAF在雄性中诱导ODC的能力比雌性更强。关于TAT活性也有类似的观察结果。如果ODC的诱导表明具有肿瘤促进特性,那么此处给出的数据表明,完全致癌物AAF和N-OH-AAF的肿瘤促进作用不是由N-O-硫酸化介导的;这可能是由于其他代谢转化。